News wrap-up: This week's headlines, plus a new cancer screening test

As we enter the holiday season, we want to continue to keep you updated with the latest pandemic news and coverage of the veterinary industry.

Here's a look at this week’s news highlights:

• The US Food and Drug Administration (FDA) announced last month the approval of Stelfonta (tigilanol tiglate injection), the first intratumoral injection to treat nonmetastatic cutaneous mast cell tumors (MCTs) in dogs.
• VolitionRX Limited (through its subsidiary Volition Veterinary Diagnostics Development LLC) released the Nu.Q Vet Cancer Screening Test. This enzyme-linked immunosorbent assay (ELISA)–based test is noninvasive, inexpensive, and easy to use.
• A spirited boxer named Chopper won the “Most Unusual Pet Insurance Claim of the Year” at the 12th annual Hambone Awards, presented by Nationwide.
• This week, we were excited to announce that we are hosting several live free webinars this month.